Wenger Vieli advised vascular implants specialist Xeltis on its financing round, raising approximately EUR 50 million. The sum includes up to EUR 37.5 million from the European Investment Bank (EIB) and EUR 10 million from existing shareholders such
Tags :xeltis
Wenger Vieli has acted as legal advisor to Xeltis, a clinical-stage company developing medical devices enabling cardiovascular restoration, on securing EUR 15 million in equity and license fees from the lead investor as cornerstone funding in
